YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(2)
- Australia(8)
- Austria(3)
- Belgium(2)
- Brazil(1)
- Canada(94)
- China(21)
- Colombia(1)
- Denmark(3)
- Egypt(1)
- Finland(2)
- France(21)
- Georgia(1)
- Germany(49)
- Greece(1)
- Hong Kong(2)
- Hungary(2)
- India(100)
- Ireland(1)
- Israel(5)
- Italia (7)
- Japan(3)
- Malta(1)
- Mauritius(1)
- Mexico(1)
- Norway(1)
- Peru(1)
- Poland(1)
- Portugal(4)
- Russia(1)
- Singapore(1)
- Slovenia(1)
- South Korea(3)
- Spain(13)
- Sri Lanka(1)
- Sweden(2)
- Switzerland(28)
- Taiwan(5)
- The Czech Republic(1)
- The Netherlands(4)
- Turkey(2)
- Ukraine(1)
- United Kingdom(87)
- United States(1017)
- Vietnam(1)
Contract Service Directory
Company Headquarters
2 Schachenweg
Rupperswil, AG 5102
Switzerland
Company Description
Zile is a Contract Development and Manufacturing Organization (CDMO) specialized in the development and manufacturing of solid and centre filled lozenges for the OTC and dietary supplement industry. We offer the whole service from formulation, scale up to manufacturing and packaging operation. We provide the expertise and technology to accelerate client success.
Contract Service Directory
- Contract Manufacturing
- Contract Packaging
- Drug Delivery Systems
- Formulation Development
- Manufacturing, Dose Form, Non-Sterile
- Manufacturing, Generics
- Manufacturing, Nutraceuticals
- Manufacturing, Oral Drug Delivery
- Manufacturing, OTC
- Manufacturing, Solid Dosage
- Packaging, Blister
- Packaging, OTC
- Packaging, Pouches
- Packaging, Solid Dosage
Contract Services Directory
Related Content
-
CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status
The arrival of patient-centric CDMO’s predicted by CPhI Annual Report.11.14.19
-
Bio News | Breaking News | Industry News | Information Technology
Goodwin Bio Launches Digitization Initiative
Invests in a sophisticated electronic quality solution.11.11.19
-
cGMP Manufacture | Drug Development
Contract Pharma’s 20th Anniversary Series: CDMO Insight
JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.Kristin Brooks, Contract Pharma 11.01.19
-
Breaking News | cGMP Manufacture | Industry News
ANI Launches New CDMO Brand ANI Global Source
Following the integration of WellSpring, the specialty CDMO will support late stage development and commercial manufacture of pharmaceutical products.10.29.19
-
Regulatory Affairs | Serialization
Fighting Back!
The drug industry takes a bare-knuckle approach to drug counterfeiters.Daniela Geiger, Vetter 10.04.19
-
Breaking News | Industry News | Regulatory Affairs
LSNE's Spain Site Gets FDA Approval
LSNE-León is the fourth facility to gain commercial approval10.04.19
-
Breaking News | Collaborations & Alliances | Industry News | Information Technology | Supply Chain
Almac Participates in Global Clinical Supply BlockChain Working Group
Project spearheaded by Biogen and Pfizer explores how technology can address the growing demands of clinical trials09.18.19
-
Vetter’s Chicago Site Wins Award ‘One of Best and Brightest Companies to Work For ®’
Winning companies recognized for making better business, creating richer lives and building a stronger community as a whole
-
Cytotoxics and High Potency Manufacturing
-
Breaking News | Industry News | Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids
Upperton Pharma Solutions Investment Increases Tabletting Capabilities
New Futorque X tablet press is designed to support R&D studies and production batches09.16.19
-
Breaking News | Industry News | Inspections
Bora Secures FDA Approval for CDMO Services
Reports successful inspection of Zhunan, Taiwan site09.03.19
-
Preparing for Your CDMO Selection Process
Finding the CDMO that is right for your company and project can be a daunting task, particularly if this is your first time outsourcing.
-
APIs | Breaking News | Industry News
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Axovant, Yposkesi Sign Gene Therapy Deal
CDMO to support the global development and commercialization of Axovant’s gene therapy programs06.20.19
